Sam Brusco, Associate Editor06.13.23
BD (Becton, Dickinson and Company) has launched the BD FACSDuet premium sample preparation system, an automated instrument that prepares samples for clinical diagnostics using flow cytometry.
The system uses liquid-handling robotics to automate sample preparation for in-vitro diagnostics and user-defined tests, including cocktailing, washing, and centrifuging. It then automatically transfers samples to the BD FACSLyric clinical flow cytometry system without human interaction.
Because it’s integrated with the flow cytometer, the BD FACSDuet premium system provides a “walkaway” workflow solution with fewer manual steps, fewer resources, and less user hands-on time. Flow cytometry is essential for clinical diagnostics and commonly used to diagnose and treat diseases like cancer.
"Our clinical customers have long trusted BD and our best-in-class products to standardize every step of the clinical lab workflow—from panel creation to sample preparation to analysis to report," Steve Conly, worldwide president of BD Biosciences told the press. "The flagship BD FACSLyric Flow Cytometry System is one of the fastest adopted clinical instruments in the world and now together with the FACSDuet Premium System, which has achieved IVD status in the U.S. and Europe, we usher in greater levels of automation so that our customers can focus more of their valuable time on analyzing and interpreting samples and impacting outcomes."
Last week, BD held a grand opening ceremony last week for a new €4 million research and development facility in Blackrock, Dublin and announced a further €30 million investment to expand its Enniscothy, Wexford manufacturing facility.
The system uses liquid-handling robotics to automate sample preparation for in-vitro diagnostics and user-defined tests, including cocktailing, washing, and centrifuging. It then automatically transfers samples to the BD FACSLyric clinical flow cytometry system without human interaction.
Because it’s integrated with the flow cytometer, the BD FACSDuet premium system provides a “walkaway” workflow solution with fewer manual steps, fewer resources, and less user hands-on time. Flow cytometry is essential for clinical diagnostics and commonly used to diagnose and treat diseases like cancer.
"Our clinical customers have long trusted BD and our best-in-class products to standardize every step of the clinical lab workflow—from panel creation to sample preparation to analysis to report," Steve Conly, worldwide president of BD Biosciences told the press. "The flagship BD FACSLyric Flow Cytometry System is one of the fastest adopted clinical instruments in the world and now together with the FACSDuet Premium System, which has achieved IVD status in the U.S. and Europe, we usher in greater levels of automation so that our customers can focus more of their valuable time on analyzing and interpreting samples and impacting outcomes."
Last week, BD held a grand opening ceremony last week for a new €4 million research and development facility in Blackrock, Dublin and announced a further €30 million investment to expand its Enniscothy, Wexford manufacturing facility.